Public Notice of Intent

Antimicrobial Stewardship


Designation Number: HSO 5030

Standards notification on a: New Development

Type of Standard: Intervention

Status: Open for comment (15 days)

Responsible Technical CommitteeTC004 – Medication Management

Project Need: HSO is convening a standards Technical Committee to revise the current standard for Antimicrobial Stewardship.The intention in revising this standard is to expand its current scope, based on client feedback and research, to long-term care and primary care organizations. Patient involvement in AMS will also be included in the standard.


HSO has decided to convene a standards Technical Committee to revise the current safety intervention standard for Antimicrobial Stewardship HSO 5030:2012

The AMS Safety Intervention Standard provides requirements for organizations to have a comprehensive, evidence-informed antimicrobial stewardship program. The program includes appropriate selection, dosing, route, and duration of antimicrobial therapy. The primary focus of an antimicrobial stewardship program is to optimize antimicrobial use to achieve the best patient outcomes, reduce the risk of infections, reduce or stabilize levels of antibiotic resistance, and promote patient safety.

Developing prescriptive clinical guidelines that specify the details of the AMS program organizations should have will be out of scope.

This standard is intended for both acute and community health care organizations such as hospitals, long term care, and primary care in Canada and globally.

 Applicability: Global

Proposed Timeline: April 2018 to October 2019

Posted on: July 23rd, 2018

Contact Information: HSO encourages ongoing feedback on its standards. If you are interested in providing comments on the standard at this stage, please contact Stakeholders that are interested in supporting the development of this standard, or would like to be consulted during the development process, may also contact us at


Click here to return to the full list of notices of intent.